Clinical Trial Update: HER2 FPBMC in Patients With Metastatic Breast and Prostate Cancer (AM006) [Phase 1, Phase 2]

View source ↗

Summary

This is an update on an ongoing Phase 1/Phase 2 trial of HER2 FPBMC in metastatic breast and prostate cancer, with status not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Prostate Cancer

Drugs mentioned

• HER2 FPBMC

Snippet

Sponsor: University of Virginia | Conditions: Breast Cancer, Prostate Cancer | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING